Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 212

1.

Calcitonin-gene related peptide and disease activity in cluster headache.

Snoer A, Vollesen ALH, Beske RP, Guo S, Hoffmann J, Fahrenkrug J, Jørgensen NR, Martinussen T, Jensen RH, Ashina M.

Cephalalgia. 2019 Mar 9:333102419837154. doi: 10.1177/0333102419837154. [Epub ahead of print]

PMID:
30854880
2.

Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.

Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J; International Headache Society Clinical Trials Standing Committee.

Cephalalgia. 2019 Feb 26:333102419828967. doi: 10.1177/0333102419828967. [Epub ahead of print]

PMID:
30806518
3.

Fetal Primary Small Bowel Volvulus Associated with Acute Gastric Dilatation Detected by Ultrasonography.

Fukushima S, Fujioka K, Ashina M, Ohyama S, Ikuta T, Nishida K, Miyauchi H, Okata Y, Bitoh Y, Tanimura K, Deguchi M, Yamada H, Iijima K.

Kobe J Med Sci. 2019 Jan 11;64(4):E157-E159.

4.

DNA methylation of the Rtl1 promoter in the placentas with fetal growth restriction.

Fujioka K, Nishida K, Ashina M, Abe S, Fukushima S, Ikuta T, Ohyama S, Morioka I, Iijima K.

Pediatr Neonatol. 2019 Jan 5. pii: S1875-9572(18)30550-3. doi: 10.1016/j.pedneo.2019.01.001. [Epub ahead of print]

5.

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.

Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas DD, Martelletti P.

J Headache Pain. 2019 Jan 16;20(1):6. doi: 10.1186/s10194-018-0955-y.

6.

Meningeal contribution to migraine pain: a magnetic resonance angiography study.

Khan S, Amin FM, Christensen CE, Ghanizada H, Younis S, Olinger ACR, de Koning PJH, Larsson HBW, Ashina M.

Brain. 2019 Jan 1;142(1):93-102. doi: 10.1093/brain/awy300.

PMID:
30590467
7.

The most important advances in headache research in 2018.

Ashina M.

Lancet Neurol. 2019 Jan;18(1):5-6. doi: 10.1016/S1474-4422(18)30434-4. No abstract available.

PMID:
30563683
8.

Cortical abnormalities in episodic migraine: A multi-center 3T MRI study.

Magon S, May A, Stankewitz A, Goadsby PJ, Schankin C, Ashina M, Amin FM, Seifert CL, Mallar Chakravarty M, Müller J, Sprenger T.

Cephalalgia. 2018 Dec 10:333102418795163. doi: 10.1177/0333102418795163. [Epub ahead of print]

PMID:
30525946
9.

High doses of ANP and BNP exacerbate lipolysis in humans and the lipolytic effect of BNP is associated with cardiac triglyceride content in pigs.

Bartels ED, Guo S, Kousholt BS, Larsen JR, Hasenkam JM, Burnett J Jr, Nielsen LB, Ashina M, Goetze JP.

Peptides. 2019 Feb;112:43-47. doi: 10.1016/j.peptides.2018.11.003. Epub 2018 Nov 30.

PMID:
30508635
10.

Migraine induction with calcitonin gene-related peptide in patients from erenumab trials.

Christensen CE, Younis S, Deen M, Khan S, Ghanizada H, Ashina M.

J Headache Pain. 2018 Nov 8;19(1):105. doi: 10.1186/s10194-018-0927-2.

11.

Neonatal vitamin K deficiency in the son of a mother with short bowel syndrome.

Ashina M, Fujioka K, Nishida K, Iijima K.

Pediatr Int. 2018 Oct;60(10):991-992. doi: 10.1111/ped.13684. Epub 2018 Oct 8. No abstract available.

PMID:
30298697
12.

Early onset of efficacy with erenumab in patients with episodic and chronic migraine.

Schwedt T, Reuter U, Tepper S, Ashina M, Kudrow D, Broessner G, Boudreau GP, McAllister P, Vu T, Zhang F, Cheng S, Picard H, Wen S, Kahn J, Klatt J, Mikol D.

J Headache Pain. 2018 Oct 1;19(1):92. doi: 10.1186/s10194-018-0923-6.

13.

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation.

Bendtsen L, Sacco S, Ashina M, Mitsikostas D, Ahmed F, Pozo-Rosich P, Martelletti P.

J Headache Pain. 2018 Sep 26;19(1):91. doi: 10.1186/s10194-018-0921-8.

14.

Migraine and cluster headache - the common link.

Vollesen AL, Benemei S, Cortese F, Labastida-Ramírez A, Marchese F, Pellesi L, Romoli M, Ashina M, Lampl C; School of Advanced Studies of the European Headache Federation (EHF-SAS).

J Headache Pain. 2018 Sep 21;19(1):89. doi: 10.1186/s10194-018-0909-4. Review.

15.

Effect of the H1-antihistamine clemastine on PACAP38 induced migraine.

Vollesen LH, Guo S, Andersen MR, Ashina M.

Cephalalgia. 2018 Aug 30:333102418798611. doi: 10.1177/0333102418798611. [Epub ahead of print]

PMID:
30165750
16.

Feeding interval and use of donor breast milk for very low birthweight infants: A nationwide survey in Japan.

Ashina M, Fujioka K, Totsu S, Shoji H, Miyazawa T, Wada K, Iijima K, Morioka I.

Pediatr Neonatol. 2018 Jul 21. pii: S1875-9572(18)30235-3. doi: 10.1016/j.pedneo.2018.07.006. [Epub ahead of print]

17.

Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding.

Deen M, Hougaard A, Hansen HD, Svarer C, Eiberg H, Lehel S, Knudsen GM, Ashina M.

Cephalalgia. 2018 Aug 8:333102418793642. doi: 10.1177/0333102418793642. [Epub ahead of print]

PMID:
30089402
18.

Current understanding of thalamic structure and function in migraine.

Younis S, Hougaard A, Noseda R, Ashina M.

Cephalalgia. 2018 Aug 4:333102418791595. doi: 10.1177/0333102418791595. [Epub ahead of print]

PMID:
30079744
19.

Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.

Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, Ashina M.

JAMA Neurol. 2018 Oct 1;75(10):1187-1197. doi: 10.1001/jamaneurol.2018.1675.

PMID:
29987329
20.

Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.

Ashina M, Tepper S, Brandes JL, Reuter U, Boudreau G, Dolezil D, Cheng S, Zhang F, Lenz R, Klatt J, Mikol DD.

Cephalalgia. 2018 Sep;38(10):1611-1621. doi: 10.1177/0333102418788347. Epub 2018 Jul 8.

PMID:
29984601

Supplemental Content

Loading ...
Support Center